biotech company developing a novel and promising type 2 diabetes drug
AdipoPharma has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Strasbourg, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-23 | Series A | — |
| Good Growth Capital,Newton Biocapital II |
| View deal → |
